Abstract: The invention provides the use of a whey protein hydrolysate in an edible composition the whey protein hydrolysate being able to induce the cellular release of glucagon-like-peptides and cholecystokinins and/or increasing glucose uptake in target tissues, wherein the whey protein hydrolysate regulates blood glucose levels or results in, or is used for, improving or preventing decline in mental performance and/or for providing a sustained feeling of energy and/or for maintaining or providing a feeling of well-being during the post-prandial period in a subject consuming the composition.

Abstract: Our invention concerns a mixture of CLA glycerides, and/or CLA-fatty acids and or CLA-alkyl esters and another component, wherein the other component (=component A) is selected for its capacity to alleviate problems related to insulin resistance in mammals, using CLA rich diets and/or foods and/or food supplements using an appropriate in vitro test so that in at least one step of the in vitro test, as described in the text, an improvement in test results is obtained of at least 4% by the blend of the CLA derivative and component A when compared to the CLA derivative only. The inventon further concerns CLA rich dietic food, food supplements and foods containing the combination of CLA and component A as defined, while also the use of this combination for achieving an alleviation of insulin resistance is part of the invention.

Abstract: A topical composition comprising: (a) conjugated linoleic acid and/or derivatives thereof; (b) a phenolic compound or mixtures thereof; and (c) a dermatologically acceptable vehicle; with the proviso that the phenolic compound is not a sunscreen. The product is particularly useful for treating wrinkles and soothing sensitive skin.

Abstract: Our invention concerns a mixture of CLA glycerides, and/or CLA-fatty acids and or CLA-alkyl esters and another component, wherein the other component (=component A) is selected for its capacity to alleviate problems related to insulin resistance in mammals, using CLA rich diets and/or foods and/or food supplements using an appropriate in vitro test so that in at least one step of the in vitro test, as described in the text, an improvement in test results is obtained of at least 4% by the blend of the CLA derivative and component A when compared to the CLA derivative only.

Abstract: Pinolenic acid can be used in the form of a food supplement, a pharmacentical composition or as part of a food composition as anti-inflammatory agent. The pinolenic acid used herefore suitably is applied as a natural product, or as a concentrate with more than 28 wt % pinolenic acid. The concentrates can be made by a process, wherein an enzymic hydrolysis on a glyceride material is performed.

Abstract: A topical composition comprising: (a) petroselinic acid and/or derivatives thereof; (b) a phenolic compound and/or mixtures thereof; and (c) a dermatologically acceptable vehicle. The product is particularly useful for treating wrinkles and soothing sensitive skin.

Abstract: Use in a topical hair composition of a compound selected from a TCA cycle intermediate, an amino acid which is catabolized to be consumed in the TCA cycle, a fatty acid, a glycolysis product, a sugar or a carbohydrate, for the purposes of participating in the oxygen consumption of a hair follicle.